Andrew J. Last Oncocyte Corp (OCX) insider trading activity

OCX Quotes by TradingView

Andrew J. Last is Director of Oncocyte Corp. Currently has a direct ownership of 90,170 shares of OCX, which is worth approximately $196,570. The most recent transaction as insider was on Jun 23, 2023, when has been sold 20,000 shares (Common Stock, No Par Value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.2K
0% 3M change
0% 12M change
Total Value Held $196,570

Andrew J. Last Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 18.15%
90,170 Common Stock, No Par V...
Aug 17 2022
BUY
Open market or private purchase
$17,400 $0.87 p/Share
20,000 Added 22.18%
70,170 Common Stock, No Par V...
Aug 15 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 16.62%
50,170 Common Stock, No Par V...
Jun 24 2022
BUY
Exercise of conversion of derivative security
-
10,000 Added 19.93%
40,170 Common Stock, No Par V...
Jun 11 2021
BUY
Exercise of in-the-money or at-the-money derivatives securities
$20,979 $3.0 p/Share
6,993 Added 18.82%
30,170 Common Stock
Dec 11 2020
BUY
Grant, award, or other acquisition
-
16,184 Added 41.12%
23,177 Common Stock

Also insider at

BIO
BIO-RAD LABORATORIES, INC. Healthcare
EVP, Chief Operating Officer
AJL

Andrew J. Last

Director
Irvine, CA

Track Institutional and Insider Activities on OCX

Follow Oncocyte Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

News

Receive news related to Oncocyte Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCX